Head And Neck Cancer (Oncology) – Drugs In Development, 2021

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Drugs In Development, 2021, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer – Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 23, 257, 225, 4, 8, 172, 42 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 14, 12, 1, 25, 4 and 1 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).

– The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

2A Pharma AB

4D Pharma Plc

4SC AG

A2 Biotherapeutics Inc

Aadi Bioscience Inc

ABBA Therapeutics AG

AbbVie Inc

Abion Inc

Accendatech Co Ltd

Achilles Therapeutics UK Ltd

Actuate Therapeutics Inc

Adaptimmune Therapeutics Plc

ADC Therapeutics SA

Adlai Nortye Biopharma Co Ltd

Advanced Accelerator Applications SA

Advaxis Inc

Advenchen Laboratories LLC

Adze Biotechnology Inc

Affimed GmbH

AGC Biologics SpA

Agenus Inc

Akeso Inc

Alkermes Plc

Alligator Bioscience AB

Alphageneron-Pharmaceuticals Inc

Alphamab Oncology

ALX Oncology Holdings Inc

Ambrx Biopharma Inc

amcure GmbH

Amgen Inc

AMI Onco Theranostics LLC

AnBogen Therapeutics

ANP Technologies Inc

Anteris Technologies Ltd

AP Biosciences Inc

Glycomantra Inc

GlycoMira Therapeutics Inc

Glycostem Therapeutics BV

Glycotope GmbH

Gossamer Bio Inc

GT Biopharma Inc

Guangzhou Bairui Biomedical Technology Co Ltd

Guangzhou BeBetter Medicine Technology Co Ltd

Guangzhou Doublle Bioproduct Inc

Guangzhou Hanghua Bio Pharmaceutical Technology Co

Guangzhou Sinogen Pharmaceutical Co Ltd

Harbin Gloria Pharmaceuticals Co Ltd

Harbour BioMed (Guangzhou) Co Ltd

HDT Bio Corp

Henan Topfond Pharmaceutical TCM Co Ltd

Hengenix Biotech Inc

Hercules Pharmaceuticals BV

HitGen Inc

Hookipa Pharma Inc

Horizon Therapeutics Plc

Huabo Biopharm (Shanghai) Co Ltd

Hummingbird Bioscience Pte Ltd

HylaPharm

I-Mab

Ideaya Biosciences Inc

Idera Pharmaceuticals Inc

IGM Biosciences Inc

ImCheck Therapeutics SAS

ImmuneSensor Therapeutics Inc

Immunicum AB

ImmunityBio Inc

Immunocore Holdings Plc

Immunogenesis Inc

Immunomic Therapeutics Inc

Immutep Ltd

Immvira Co Ltd

Imugene Ltd

IMV Inc

Incyte Corp

Infinity Pharmaceuticals Inc

Inhibrx Inc

Innate Pharma SA

InnoMab Pte Ltd

Innovene

Innovent Biologics Inc

Inovio Pharmaceuticals Inc

Instil Bio UK Ltd

Intensity Therapeutics Inc

InteRNA Technologies BV

Invectys SA

InxMed Shanghai Co Ltd

IO Biotech ApS

Iovance Biotherapeutics Inc

ISA Pharmaceuticals BV

Istari Oncology Inc

iSTAT Therapeutics Inc

ISU ABXIS Co Ltd

iTeos Therapeutics Inc

Jacobio Pharmaceuticals Group Co Ltd

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Kanion Pharmaceutical Co Ltd

Jiangsu Vcare PharmaTech Co Ltd

Jina Pharmaceuticals Inc

Johnson & Johnson

Joint Biosciences Ltd

Jounce Therapeutics Inc

Karyopharm Therapeutics Inc

Kintara Therapeutics Inc

Komipharm International Co Ltd

Kuur Therapeutics Ltd

Kymab Ltd

Kyowa Kirin Co Ltd

L.E.A.F. Pharmaceuticals LLC

Laboratoires Pierre Fabre SA

LATITUDE Pharmaceuticals Inc

Leucid Bio Ltd

Lidds AB

LIfT BioSciences Ltd

LightOx Ltd

Linnaeus Therapeutics Inc

Lion TCR Pte Ltd

LipoSeuticals Inc

Luminus Biosciences Inc

Luye Pharma Group Ltd

Luzitin SA

Lycera Corp

LynkCell Inc

Lytix Biopharma AS

Mabion SA

Mabpharm Ltd

MacroGenics Inc

MAIA Biotechnology Inc

Marsala Biotech Inc

Mateon Therapeutics Inc

Maverick Therapeutics Inc

MaxiVAX SA

MediciNova Inc

Mekanistic Therapeutics LLC

Merck & Co Inc

Merck KGaA

Mereo Biopharma Group Plc

Mersana Therapeutics Inc

Merus NV

Metaclipse Therapeutics Corp

Millennium Pharmaceuticals Inc

MiNK Therapeutics Inc

Mirati Therapeutics Inc

MiRecule Inc

MiReven Pty Ltd

Mitsubishi Tanabe Pharma Corp

Moderna Inc

Modra Pharmaceuticals BV

Molecular Partners AG

Molecular Templates Inc

Moleculin Biotech Inc

Morphogenesis Inc

MultiVir Inc

Nanjing Iaso Biotherapeutics Co Ltd

Nanjing Sanhome Pharmaceutical Co Ltd

NanoCarrier Co Ltd

NantBioScience Inc

Natco Pharma Ltd

Nektar Therapeutics

Neonc Technologies Inc

NeoTX Therapeutics Ltd

Neumedicines Inc

NextCure Inc

NGM Biopharmaceuticals Inc

Northwest Biotherapeutics Inc

Novartis AG

Noxopharm Ltd

Nubiyota LLC

Obsidian Therapeutics Inc

Ocellaris Pharma Inc

Ona Therapeutics SL

OncoC4 Inc

Oncolys BioPharma Inc

Onconova Therapeutics Inc

Oncorus Inc

OncoSec Medical Inc

Oncovir Inc

OncXerna Therapeutics Inc

Ono Pharmaceutical Co Ltd

Onxeo SA

Ovensa Inc

Oxford Vacmedix UK Ltd

Pact Pharma Inc

Papivax LLC

PDS Biotechnology Corp

Pfizer Inc

Pharma Mar SA

Pharmaxis Ltd

Philogen SpA

Phio Pharmaceuticals Corp

Phosplatin Therapeutics LLC

Pionyr Immunotherapeutics Inc

PIQUR Therapeutics AG

PlantForm Corp

Plexxikon Inc

Plus Therapeutics Inc

PNP Therapeutics Inc

Polaris Pharmaceuticals Inc

Potenza Therapeutics Inc

Precigen Inc

Prelude Therapeutics Inc

PRISM Pharma Co Ltd

Privo Technologies Inc

Protheragen Inc

Provectus Biopharmaceuticals Inc

PsiOxus Therapeutics Ltd

Psivac Ltd

Puma Biotechnology Inc

Purple Biotech Ltd

QBiotics Group Ltd

Qilu Pharmaceutical Co Ltd

Qilu Puget Sound Biotherapeutics Corp

Qrono Inc

Quadriga BioSciences Inc

R-Pharm

Rakuten Medical Inc

RAPT Therapeutics Inc

RaQualia Pharma Inc

Refuge Biotechnologies Inc

Regeneron Pharmaceuticals Inc

RemeGen Co Ltd

Repertoire Immune Medicines Inc

Reven Pharmaceuticals Inc

Rubius Therapeutics Inc

Sanofi

Sareum Holdings Plc

Scancell Holdings Plc

Scopus BioPharma Inc

Seagen Inc

SEEKYO Therapeutics

Seven and Eight Biopharmaceuticals Corp

Shanghai De Novo Pharmatech Co Ltd

Shanghai GeneChem Co Ltd

Shanghai Henlius Biotech Inc

Shanghai Institute of Biological Products Co Ltd

Shanghai Jing Ze Biotechnology Co Ltd

Shanghai Junshi Bioscience Co Ltd

Shanghai Miracogen Inc

Shanghai Novamab Biopharmaceuticals Co Ltd

Shattuck Labs Inc

Shenghe (China) Biopharmaceutical Co Ltd

Shionogi & Co Ltd

Sichuan Kelun Pharmaceutical Co Ltd

Silverback Therapeutics Inc

Simcha Therapeutics Inc

Sino Biopharmaceutical Ltd

Sirnaomics Inc

Sirona Therapeutics Inc

SL Bigen Inc

Smerud Medical Research International AS

SN BioScience

Sonnet BioTherapeutics Holdings Inc

Soricimed Biopharma Inc

Sotio AS

SQZ Biotechnologies Co

Starpharma Holdings Ltd

STAT3 Therapeutics Inc

Stcube Inc

Stella Pharmaceuticals Pvt Ltd

Sumitomo Dainippon Pharma Co Ltd

Sumitomo Dainippon Pharma Oncology, Inc

Sutro Biopharma Inc

SuviCa Inc

Suzhou Dingfu Target Biotechnology Co Ltd

Suzhou Maximum Bio-tech Co Ltd

Suzhou Neupharma Co Ltd

Suzhou Teligene Ltd

Suzhou Zanrong Pharmaceutical Technology Co Ltd

Suzhou Zelgen Biopharmaceutical Co Ltd

Sveikatal Inc

Symphogen A/S

Synermore Biologics Co Ltd

Synthorx Inc

Syntrix Biosystems Inc

Systimmune Inc

Tactical Therapeutics Inc

TAE Life Sciences LLC

Tailored Therapeutics LLC

Takeda Pharmaceutical Co Ltd

Takis Srl

Tallikut Pharmaceuticals Inc

TCR Cure Biopharma Technology Co Ltd

Telix Pharmaceuticals Ltd

TempestTx, Inc.

Tessa Therapeutics Ltd

Tetranov International Inc

Theralase Technologies Inc

Theravectys SA

Tmunity Therapeutics Inc

TOLREMO Therapeutics AG

Touchlight Genetics Ltd

Transgene SA

Treadwell Therapeutics Inc

Tuhura Biopharma Inc

Turning Point Therapeutics Inc

Turnstone Biologics Inc

Tvardi Therapeutics Inc

Tyme Inc

UbiVac LLC

UCB SA

Ultimovacs AS

United Immunity Co Ltd

Vaccinex Inc

VasGene Therapeutics Inc

Vault Pharma Inc

VCN Biosciences SL

Vectorite Biomedical Inc

Venus Remedies Ltd

Versameb AG

Viracta Therapeutics Inc

Viralytics Pty Ltd

Virion Therapeutics LLC

Virocure Inc

VM Discovery Inc

Voronoi Group

Vyriad Inc

Waterstone Hanxbio Pty Ltd

Wayshine Biopharma Inc

WindMIL Therapeutics Inc

Wugen Inc

Wuhan Binhui Biotechnology Co Ltd

Xbrane Biopharma AB

Xencor Inc

Xiangxue Life Sciences

XuanZhu Biological Technology Co Ltd

Xynomic Pharmaceuticals Holdings Inc

Y-Biologics Inc

Zhejiang Yangshengtang Biotech Co Ltd

Zymeworks Inc

Table of Contents

Table of Contents

Introduction

Head And Neck Cancer - Overview

Head And Neck Cancer - Therapeutics Development

Head And Neck Cancer - Therapeutics Assessment

Head And Neck Cancer - Companies Involved in Therapeutics Development

Head And Neck Cancer - Drug Profiles

Head And Neck Cancer - Dormant Projects

Head And Neck Cancer - Discontinued Products

Head And Neck Cancer - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Head And Neck Cancer, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Head And Neck Cancer – Pipeline by 2A Pharma AB, 2021

Head And Neck Cancer – Pipeline by 4D Pharma Plc, 2021

Head And Neck Cancer – Pipeline by 4SC AG, 2021

Head And Neck Cancer – Pipeline by A2 Biotherapeutics Inc, 2021

Head And Neck Cancer – Pipeline by Aadi Bioscience Inc, 2021

Head And Neck Cancer – Pipeline by ABBA Therapeutics AG, 2021

Head And Neck Cancer – Pipeline by AbbVie Inc, 2021

Head And Neck Cancer – Pipeline by Abion Inc, 2021

Head And Neck Cancer – Pipeline by Accendatech Co Ltd, 2021

Head And Neck Cancer – Pipeline by Achilles Therapeutics UK Ltd, 2021

Head And Neck Cancer – Pipeline by Actuate Therapeutics Inc, 2021

Head And Neck Cancer – Pipeline by Adaptimmune Therapeutics Plc, 2021

Head And Neck Cancer – Pipeline by ADC Therapeutics SA, 2021

Head And Neck Cancer – Pipeline by Adlai Nortye Biopharma Co Ltd, 2021

Head And Neck Cancer – Pipeline by Advanced Accelerator Applications SA, 2021

Head And Neck Cancer – Pipeline by Advaxis Inc, 2021

Head And Neck Cancer – Pipeline by Advenchen Laboratories LLC, 2021

Head And Neck Cancer – Pipeline by Adze Biotechnology Inc, 2021

Head And Neck Cancer – Pipeline by Affimed GmbH, 2021

Head And Neck Cancer – Pipeline by AGC Biologics SpA, 2021

Head And Neck Cancer – Pipeline by Agenus Inc, 2021

Head And Neck Cancer – Pipeline by Akeso Inc, 2021

Head And Neck Cancer – Pipeline by Alkermes Plc, 2021

Head And Neck Cancer – Pipeline by Alligator Bioscience AB, 2021

Head And Neck Cancer – Pipeline by Alphageneron-Pharmaceuticals Inc, 2021

Head And Neck Cancer – Pipeline by Alphamab Oncology, 2021

Head And Neck Cancer – Pipeline by ALX Oncology Holdings Inc, 2021

Head And Neck Cancer – Pipeline by Ambrx Biopharma Inc, 2021

Head And Neck Cancer – Pipeline by amcure GmbH, 2021

Head And Neck Cancer – Pipeline by Amgen Inc, 2021

Head And Neck Cancer – Pipeline by AMI Onco Theranostics LLC, 2021

Head And Neck Cancer – Pipeline by AnBogen Therapeutics, 2021

Head And Neck Cancer – Pipeline by ANP Technologies Inc, 2021

Head And Neck Cancer – Pipeline by Anteris Technologies Ltd, 2021

Head And Neck Cancer – Pipeline by AP Biosciences Inc, 2021

Head And Neck Cancer – Pipeline by Apexigen Inc, 2021

Head And Neck Cancer – Pipeline by Apollomics Inc, 2021

Head And Neck Cancer – Pipeline by Arch Oncology Inc, 2021

Head And Neck Cancer – Pipeline by Arcus Biosciences Inc, 2021

Head And Neck Cancer – Pipeline by Immvira Co Ltd, 2021

Head And Neck Cancer – Pipeline by Imugene Ltd, 2021

Head And Neck Cancer – Pipeline by IMV Inc, 2021

Head And Neck Cancer – Pipeline by Incyte Corp, 2021

Head And Neck Cancer – Pipeline by Infinity Pharmaceuticals Inc, 2021

Head And Neck Cancer – Pipeline by Inhibrx Inc, 2021

Head And Neck Cancer – Pipeline by Innate Pharma SA, 2021

Head And Neck Cancer – Pipeline by InnoMab Pte Ltd, 2021

Head And Neck Cancer – Pipeline by Innovene, 2021

Head And Neck Cancer – Pipeline by Shanghai Jing Ze Biotechnology Co Ltd, 2021

Head And Neck Cancer – Pipeline by Shanghai Junshi Bioscience Co Ltd, 2021

Head And Neck Cancer – Pipeline by Shanghai Miracogen Inc, 2021

Head And Neck Cancer – Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2021

Head And Neck Cancer – Pipeline by Shattuck Labs Inc, 2021

Head And Neck Cancer – Pipeline by Shenghe (China) Biopharmaceutical Co Ltd, 2021

Head And Neck Cancer – Pipeline by Shionogi & Co Ltd, 2021

Head And Neck Cancer – Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, 2021

Head And Neck Cancer – Pipeline by Silverback Therapeutics Inc, 2021

Head And Neck Cancer – Pipeline by Simcha Therapeutics Inc, 2021

Head And Neck Cancer – Pipeline by Sino Biopharmaceutical Ltd, 2021

Head And Neck Cancer – Pipeline by Sirnaomics Inc, 2021

Head And Neck Cancer – Pipeline by Sirona Therapeutics Inc, 2021Head And Neck Cancer – Pipeline by SQZ Biotechnologies

List of Figures

List of Figures

Number of Products under Development for Head And Neck Cancer, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports